A Study to Evaluate Oncologic Outcomes and Quality of Life in Sinonasal Cancer Patients

Overview

About this study

This is a multi-site study with several other leading centers studying sinonasal cancers. The purpose of this study is to gain a better understanding of the treatment and significant morbidity associated with sinonasal cancer and identify the impact this disease has on quality of life. In addition, several additional endpoints will focus on survival and optimal treatment strategies. Additional components will also included genomic and molecular analysis of tumor tissue as we search for novel targets for therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive).
Patients with a new diagnosis of sinonasal cancer.
Patients undergoing treatment at Mayo Clinic, Rochester, MN.

Exclusion Criteria:

Healthy individuals.
Unwilling to sign the informed consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Jacob Eide, M.D.	Open for enrollment	Contact information: Marissa Larson (507) 216-4999 Larson.Marissa@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jacob Eide, M.D.

Open for enrollment

Contact information:

Marissa Larson

(507) 216-4999

Larson.Marissa@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials